Management of Dyslipidemia for Cardiovascular Risk Reduction (Lipids)

For primary prevention in patients over age 40 and not on statin therapy who have not developed new cardiovascular risk factors (e.g., diabetes, hypertension, tobacco use), we suggest against offering a cardiovascular disease risk assessment more frequently than every five years.

For primary prevention in patients not on statin therapy, we suggest against routinely ordering a lipid panel more frequently than every 10 years.

For cardiovascular risk assessment in primary prevention, we suggest using a 10-year risk calculator.

We suggest against the routine use of coronary artery calcium testing.

We suggest against the routine use of additional risk markers (e.g., high-sensitivity C-reactive protein, ankle-brachial index, coronary artery calcium) when assessing cardiovascular risk.